Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

Launched by ACCELERATED CURE PROJECT FOR MULTIPLE SCLEROSIS · May 29, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed consent by person with MS
• • Living in the US
• • Age ≥ 22
• • Confirmed diagnosis of MS by a physician, who is a neurologist or has access to a neurologist's statement of diagnosis
• • Fatigue Severity Scale score at or above eligibility threshold
• • Fluent in English
• • Willingness to engage in self-administration of an online intervention for 24 weeks and complete follow-up assessments
• • Access to the internet and e-mail with a compatible device (smartphone, computer, or tablet)
• • No MS relapse / no steroid treatment in the 4 weeks prior to answering the screening questionnaire (self-reported)
• • No disease-modifying therapeutic (DMT) started in the 4 weeks prior to answering the screening questionnaire (self-reported)
• Exclusion Criteria:
• • Unwilling or unable to consent
• • Refusal to saving, processing and forwarding of pseudonymized data
• • Concurrent participation in another interventional trial